We found that serum VEGF, VEGFC, sFLT1, sTIE2, IL-8, and TNF-α levels could identify patients with GC based on the optimal cut-off value with AUC > 0.8 (Supplementary Fig. 9). The gene discussed is CXCL8; the disease is gastric cancer.